Center for Novel Therapeutics
The University of California, San Diego is one of the top 15 research universities in the world. Situated on the Western edge of the University’s Science Research Park, the new Center for Novel Therapeutics seeks to support the successful formation, funding, and growth of private biotech companies.
This University is bringing the pharmaceutical industry onto its campus, giving entrepreneurs and corporations more access to the university’s market-worthy research and advancing public-private collaboration.
FEASIBILITY STUDY OF AMORPHOUS SILICON PHOTOVOLTAIC SKYLIGHT IN SAN DIEGO
Reduction in HVAC energy demands
internal Rate of Return
- Total Area - 1.353 M2
- Electricity generated in 35 years - 193.531 kWh
- Total lighting points operating 4 hours per day in 35 years - 380 lighting points
- Avoided CO2 emmisions in 35 years - 130 CO2
- Barrels of oil saved in 35 years - 114 barrels
The new building, spanning 110,000 square meters is aimed mainly at start-ups engaged in research and development of therapeutics, diagnostics, and interventions with a focus on cancer.
Located at the heart of the building, a photovoltaic skylight greets visitors to the park and serves as a central collaboration space with views.
The skylight consists of amorphous silicon PV glass based on a medium degree of transparency. In addition to providing on-site power, they also provide natural light, ultraviolet, and infrared radiation filters, and permanent protection against weather conditions.
As a showcase of sustainability, the skylight will serve as the central lung for the building – filtering air and daylight into the adjacent offices/meeting areas through Onyx Solar PV glass in the skylight areas.
The architects responsible for the design of this building was Perkins + Will. The Center for Novel Therapeutics is LEED® Gold Certified thanks to the renewable energy provided by the solar PV glass of Onyx Solar.